---
title: "Xizang Weixinkang Pharmaceutical: The company does not have any significant matters that should be disclosed but have not been disclosed regarding the planning involving the company"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/237325607.md"
description: "Xizang Weixinkang Pharmaceutical announced that after self-examination and verification with the controlling shareholder, as of the announcement date, the company does not have any undisclosed significant matters, including major asset restructuring, share issuance, etc. The company's operating conditions are normal, and there have been no significant changes in the internal and external environment"
datetime: "2025-04-24T08:35:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/237325607.md)
  - [en](https://longbridge.com/en/news/237325607.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/237325607.md)
generator: "portal-rs"
---

# Xizang Weixinkang Pharmaceutical: The company does not have any significant matters that should be disclosed but have not been disclosed regarding the planning involving the company

Xizang Weixinkang Pharmaceutical issued a notice of unusual movement. After the company's self-examination and verification with the actual controller, controlling shareholders, and their concerted actors, as of the date of this announcement, there are no significant matters that should be disclosed but have not been disclosed, except for information that has been publicly disclosed in designated media. This includes but is not limited to major asset restructuring, share issuance, significant transaction matters, business restructuring, share repurchase, equity incentives, bankruptcy reorganization, major business cooperation, and the introduction of strategic investors. The company's current operating status is normal, and there have been no significant changes in the internal and external operating environment

### Related Stocks

- [603676.CN](https://longbridge.com/en/quote/603676.CN.md)

## Related News & Research

- [This Atlassian Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday](https://longbridge.com/en/news/297053341.md)
- [MedicalRite Announces COVID-19 & Flu Combo Test for Better Health](https://longbridge.com/en/news/297204162.md)
- [03:39 ETWalovi Accelerates Global Push with WALOVI Singapore HQ Launch and Trio of Southeast Asia Deals](https://longbridge.com/en/news/297003145.md)
- [Endovia Health opens FDA INAD file for CannEpil veterinary program](https://longbridge.com/en/news/296915045.md)
- [Citi Downgrades COSCO SHIP HOLD , Evergreen Marine and Yang Ming to Neutral, Adjusts TPs](https://longbridge.com/en/news/296859156.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**